Elevated ABCB1 expression is associated with MDR in several cancers, including acute myelogenous leukemia, breast cancer, and lung cancer, making it a potential prognostic marker and target for modulators [41,42,43,44]. The gene discussed is ABCB1; the disease is breast carcinoma.